Antihypertensive AgentsHypertensionBlood PressureHydrochlorothiazideDiureticsAtenololAngiotensin-Converting Enzyme InhibitorsAmlodipineCalcium Channel BlockersHydralazineMethyldopaSodium Chloride Symporter InhibitorsAdrenergic beta-AntagonistsMinoxidilBendroflumethiazideRats, Inbred SHRDoxazosinAngiotensin II Type 1 Receptor BlockersCaptoprilTetrazolesLisinoprilNordefrinGlutamyl AminopeptidaseDihydropyridinesAngiotensin Receptor AntagonistsClonidineEnalaprilIndapamideLabetalolBlood Pressure Monitoring, AmbulatoryDrug Therapy, CombinationGuanfacinePerindoprilHypertension, RenalBlood Pressure DeterminationRenin-Angiotensin SystemNifedipineBenzimidazolesImidazoline ReceptorsHeart RatePropanolaminesLosartanDiltiazemReninTreatment OutcomePrazosinRats, Inbred WKYDouble-Blind MethodChlorthalidonePatient ComplianceAdrenergic alpha-AntagonistsFumaratesSystoleBiphenyl CompoundsMedication AdherencePropranololImidazolesDose-Response Relationship, DrugClinical Trials as TopicDesoxycorticosteroneHypertension, RenovascularValineKidney Failure, ChronicKidneyPhenylacetatesDrug CombinationsTime FactorsRisk FactorsDiabetic NephropathiesBenzopyransCardiovascular DiseasesHemodynamicsFollow-Up StudiesTrichlormethiazideProteinuriaArteriesDelayed-Action PreparationsCardiovascular SystemProspective StudiesDiabetes Mellitus, Type 2Diabetes ComplicationsThiazidesAdministration, OralRandomized Controlled Trials as TopicAmidesKidney DiseasesVasodilator AgentsAortaCreatinineBenzothiadiazinesSympathetic Nervous SystemRisk AssessmentHypertrophy, Left VentricularStrokeRetrospective StudiesFelodipine